S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

REPL Replimune Group Inc

6.00

0.43 (7.72%)

May 22 2024 - Closed

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Replimune (NASDAQ:REPL)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Replimune Charts.

Replimune (NASDAQ:REPL)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Replimune Charts.

Replimune Group Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 days ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 16 May 2024 (7 days ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Thursday 16 May 2024 (7 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 16 May 2024 (7 days ago) • Edgar (US Regulatory)

Form POSASR - Post-effective Amendment to an automatic shelf registration statement
Thursday 16 May 2024 (7 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 16 May 2024 (7 days ago) • Edgar (US Regulatory)

Replimune Reports Fiscal Fourth Quarter and Year Ended 2024 Financial Results and Provides Corporate Update
Thursday 16 May 2024 (7 days ago) • GlobeNewswire Inc.

Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
Sunday 7 April 2024 (1 month ago) • GlobeNewswire Inc.

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 4 April 2024 (2 months ago) • GlobeNewswire Inc.

More Replimune Group Inc News Articles

Cytori Therapeutics

Franklin Moderate Alloca...

Canadian Imperial Bank O...

Mistango River Resources

INTESA SANPAOLO

3X Short Bitcoin SV Token

SafeGuard Core One

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions